chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Mother brought patient back 1 hour after he had the H1N1 vaccination.  Pt. mother states he was complaining of hands and feet itching and that he was wheezing.  Also complained of nonstop coughing, tiredness and had not felt this before. Mother states he looked pale. Pt. had clear breath sounds and was moving good air.  Pt. and mother waited for approximately 15 minutes and afterwards stated he was feeling fine and was not having itching to extremities anymore and mother took pt. home to monitor him.
Pt received first dose Pfizer vaccine at 1528,  at 1550, pt was in observation area and reported feeling "strange" like her throat was tight. Pt has PMH of anaphylactic reaction to multiple medications and foods. Nurse encouraged pt to begin pursed lipped breathing. At 1552 pt became SOB and felt her throat "closing". Administered 0.3mg Epinephrine IM to L quadriceps muscle, applied O2 via mask running at 12L and called 911 for ER transport. BP 138/72, HR 100, O2 sat 99% temp 98.2. Paramedics arrived at 1558, pt was stabilized and transferred to higher level of care.
Chills and aches all over; Chills and aches all over; This is a spontaneous report received from a contactable consumer (patient).A 35 year old non-pregnant female patient received second dose of BNT162B2 (BNT162B2, Formulation: solution for injection, Batch/Lot Number - el3248) via an unspecified route of administration in the right arm on 08Feb2021 at 01:15 PM (at the age of 35year old ) as single dose for COVID-19 immunization. Patient historical vaccine included first dose of BNT162B2 (BNT162B2, Formulation: solution for injection, lot number unknown) via an unspecified route of administration on 20Jan2021 at 03:30 PM as single dose for COVID-19 immunization and no known allergies. The patient received flu vaccines within 4 weeks prior to the COVID-19 vaccination. The concomitant medication includes Flu. Prior to vaccination, the patient not diagnosed with COVID-19. Since the vaccination, the patient not been tested for COVID-19.On 09Feb2021 at 09:00 AM, the patient experienced Chills and aches all over. The outcome of the event was recovering.  No follow-up attempts are possible. No further information was expected.
Seizure - Grand Mal; upon my MRI - found I had a stroke - cerebral stroke. I take seizure medications and aspirin for life. I had never had a seizure before. Doctor visit follow up and I have seen two different neurologists.
2nd Moderna vaccine administered at 1:29 pm.  - Patient has anaphlaxis with ibuprofen. Due to patient's allergies, she was observed for 30 minutes.  - When patient was called to leave at 1:59, she complained of dizziness and nausea.  - She admitted to not eating anything or drinking any water today.  - Patient was given cold water and ice applied to back of patient's neck.  - She was also food. Patient refused food and refused to drink water - Reports that she feels like she is going to pass out. - Patient requested that her son be called. Her son was called as requested and he came to clinic.  - Patient refused to elevate her feet and kept trying to stand up.  - Denies hx of DM or cardiac hx.  - Vitals were taken stable.  - She then began to complain of worsening dizziness, nausea. Followed by abdominal pain, midsternal CP, SOB, and feeling as her throat is closing.  - At 2:09pm, Epipen was ordered and administered to L thigh.  - Reports that CP, SOB, and throat swelling resolved after epinephrine.  - Patient was placed on 2L of O2.  - Fire rescue arrived. Started IV and gave patient Zofran , checked blood glucose: 141, BP: 128/101, while waiting for ambulance to arrive.  - Patient was transported via ambulance to  Medical Center.
Expired Rotarix vaccine administered orally during routine well visit - no problems, no adverse outcome, no treatment needed.
Information obtained from ER visit report: Received Typhoid injection right deltoid 12:30 PM 28 Sep 10. Pt. c/o pain during administration, worsening over time. Seen at ER 12:02 am 29 Sep 10 with c/o pain 8/10 to rt. deltoid, radiating to shoulder and back. No symptoms of allergic reaction noted. ER physician unable to tell where shot was given. Pt. received Morphine 4mg IM and Benadryl during visit. Discharged with Ultram, Benadryl, Zantac and Epi-pen. Placed on 48 hrs. quarters and instructions to exempt from future Typhoid injections.
Pt came in to store the back side of the arm is swollen and pink. We told pt he needed to see a doctor but pt said he had no insurance. Told pt to try BENADRYL but will need to see MD. ASAP if continues.
Arm swollen; Arm was warm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Arm swollen) and VACCINATION SITE WARMTH (Arm was warm) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025LD08) for COVID-19 vaccination.     The patient's past medical history included Broken hip. Concurrent medical conditions included Hypertension (Moderate high blood pressure.), Clotting disorder, Heart disorder and Kidney disorder. Concomitant products included WARFARIN SODIUM (COUMADIN) and HYDROCHLOROTHIAZIDE, TRIAMTERENE (DYAZIDE) for an unknown indication.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Arm swollen) and VACCINATION SITE WARMTH (Arm was warm). On 07-Jan-2021, VACCINATION SITE SWELLING (Arm swollen) and VACCINATION SITE WARMTH (Arm was warm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.
Patient returned to office 17 days later with a red, inflamed nodule on her left nodule that she claimed started on 6/26/19.
Information has been received from a physician concerning a female who was vaccinated with a 0.5 mL first dose of GARDASIL. The patient developed high fever and was in bed for two days after receive the GARDASIL dose. No laboratories studies performed. The patient sought unspecified medical attention. The patient recovered on an unspecified date. Follow up information received on 23-JUL-2009 from a physician indicated that the patient was a 15 year old female. Concomitant therapy included an unspecified number of doses of RECOMBIVAX HB (manufacturer unknown) on unspecified dates; no problems reported with this series. On an unspecified date the patient was "very sick" and experienced high fever and chills; it was also reported that the patient couldn't get out of bed. The physician was unsure if any office, ER visit or work up by this. The patient recovered on an unspecified date. No further information is available.
Patient went to bed on 1/14/17 at around 11pm after receiving his vaccines around 1:30pm that afternoon. He noted that he did not feel too well at that point, with explaining he had mild flu-like symptoms. Around 4:30am, he woke from his sleep feeling dizzy, faint, nausea, headache, pain around the temples, and vomiting. He went to the emergency room where they administed IV saline solution and zofran. The patient was then released home shortly thereafter, and today (1/15/17 at 4pm) is feeling much better, but still having pain around the temples.
This is a spontaneous report from a contactable medical assistant received via a sales representative. A 17-year-old female patient of an unspecified race and ethnicity received a single dose of TRUMENBA (lot M77282) via an unspecified route of administration on an unspecified date for immunisation. The patient medical history and concomitant medications were not reported. The patient experienced fever, headache and malaise on an unspecified date. Outcome of the events was unknown.
angioedema report it in the throat area; chronic spontaneous urticaria; esophagus spasm; pattern is eerie, it happens 7-10 days after the booster; having similar symptoms; This spontaneous case was reported by a consumer and describes the occurrence of ANGIOEDEMA (angioedema report it in the throat area) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANGIOEDEMA (angioedema report it in the throat area) (seriousness criterion medically significant), CHRONIC SPONTANEOUS URTICARIA (chronic spontaneous urticaria), OESOPHAGEAL SPASM (esophagus spasm), FEELING ABNORMAL (pattern is eerie, it happens 7-10 days after the booster) and VACCINATION COMPLICATION (having similar symptoms). At the time of the report, ANGIOEDEMA (angioedema report it in the throat area), CHRONIC SPONTANEOUS URTICARIA (chronic spontaneous urticaria), OESOPHAGEAL SPASM (esophagus spasm), FEELING ABNORMAL (pattern is eerie, it happens 7-10 days after the booster) and VACCINATION COMPLICATION (having similar symptoms) outcome was unknown.            Other medications not provided by the reporter. The support group (called Chronic Spontaneous Urticaria with COVID19 Vaccine Support Group) with 600-700 people who took different COVID19 vaccines, like Pfizer and Moderna.  The reporter encouraged the safety team to take a look at the group because people were reporting a variety of treatments. and mixed different antihistamines.   This case was linked to MOD-2022-440894, MOD-2022-440948 (Patient Link).
This spontaneous report as received from a health care worker refers to a female patient of approximately 54 years. On an unknown date in January 2013, the patient was vaccinated with a first dose of RECOMBIVAX HB (Lot number, expiry date, route and dose were not reported). The second dose was given on an unspecified date in 2013. The patient was vaccinated with the third dose early. On an unknown date in 2013 (reported as 2 months after the second dose), the patient was vaccinated with a third dose of RECOMBIVAX HB (Lot number, expiry date, route and dose were not reported) and no adverse effects reported. Additional information is not expected.
Observed patient getting fanning patient as he became light-headed and explained blurry vision. Patient became increasingly unresponsive and pale. Immediately obtained an Epinephrine 0.3mg pen and injected into thigh, patient immediately vomited and 911 was called.
Swollen neck lymph nodes, face and neck swelling, bloodshot eyes, low grade fever, joint swelling, throat closing mostly recovered from the most severe symptoms, but still some discomfort in neck. At date of reporting March 22 most symptoms were resolved.
Patient developed itch, pain and swelling on the right side of his back. It  spread to upper and mid back, and to upper right shoulder, underarms and to the right breast.
pt recv vax 24JAN96 & 24APR96 pt devel a bilat case of mumps w/fever & swelling;pt recovered in 1wk;
Kidney stones, extreme abdominal pain, blood in urine, difficult urination -Passed 5 stones two weeks following first dose of vaccine -Passed additional stones one-per-month for 5 straight months
Temperature of 99.4; Headache; Chills; Body aches, soreness and redness with slight swelling at injection site.  All lasted for about 24 hours, except headache and redness at injection site which lasted for almost 48 hours.
low platelet counts; This is a spontaneous report received from Pfizer sponsored study. A contactable female consumer (patient herself) of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number and Expiration date was not reported) via an unspecified route of administration on 04Feb2021 as single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Patient asked if Pfizer has an idea or information if it is okay to get the second dose of Covid-19 vaccine since she was advised by her Hematologist to get some tests before getting the second dose due to her low platelet counts. Platelet count recorded as low on an unspecified date, not provided the values of the count by patient. The outcome of the event was unknown.  Information about lot/batch number has been requested.
Small rash in the site where the shot was given, itchy and red. One week after the vaccination
Headache, Myalgia, Pain at injection site Narrative: Received 2 nd Vaccine causing myalgias, headache, and pain at injection site that required her to miss work 1 day.
Pain and swelling in Left Calf muscle. Treating the blood clot with Xeralto
Mild symptoms the day after. Arm hurt, gas in my back, dizzie and light headed off and on. Then second day after my  first vaccine my varicose veins  on my left leg (shin  area) they exploded inside my leg (under the skin).  Pain and Major swelling and  bruising that night. Then continued major bruising for 2 1/2  weeks after.
Had booster shot of Pfizer  on 10/04/2021 and had 1st symptoms of pain in chest and back of neck and felt dizzy on 10/15/21...lasted a minute or so then again same symptoms on 10/27/21 lasted like 5 mins then next day 10/28/21 had 2 episodes in morning lasted about 5 minutes with 10 minutes....drove myself to hospital and I told ER that I was having heart attack.   I was kept in hospital they did a Catherization and removed blocked artery of blood clots and put in stent...It was 99.9% blocked...LAD otherwise known as the Widowmaker...lucky to be alive.. I had no prior heart problems never!  No, high Cholesterol, Blood pressure, no plague buildup in arteries...never should have happened.
nauseated, vertigo, diarrhea, headache, sore joints, left shoulder pain, fatigue
On 06/12/2021 I had excruciating pain on my right shoulder blade. I went to an orthopedist on Monday and got a codon shot and pain killer. That subsided like in 7-10 days. Meanwhile I realized I had no control on my fingers on my right hand. I had very weak grip. The physical therapist measured my strength and on the left I have 70 lb strength and on the right 10 lb. My dominant hand is the right so it should be a strong hand. As time goes by it has decreased to 5 lb. I am losing my fine motor skills on my right hand. And I have decreased muscle tone. My doctor thought it was a pinch nerve, so we took an MRI and I have Mild stenosis. Then he sent me to immunologist. He said this was a Parsonage Turner syndrome.
slept for a few hrs, when awakened was lethargic w/dec responsiveness; became pale, eyes became fixed & had dec muscle tone lasted for few seconds; resolved w/stimulation; adm for observation overnight;
Pt received H1N1 vaccination (in June?) and developed typical sx of anaphylaxis within 10-15 minutes after injection during observation (SOB, hotness, blotchy skin, no throat closure though). Received Epi/Diphenhydramine in ER and was stable.
pt developed redness, warmth mild swelling of the site No fever. Evaluated by PCP on 07/07/22 who was informed by pt that she has a latex allergy.  PCP feels there was a hypersensitivity reaction
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 75-year-old female patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included hypothyroidism and blood cholesterol increased. Concomitant products included SYNTHROID and ZOCOR. On 4th June 2018, the patient received SHINGRIX. On 13th June 2018, 9 days after receiving SHINGRIX, the patient experienced injection site erythema, injection site rash and injection site warmth. On 14th June 2018, the patient experienced swelling arm. In June 2018, the patient experienced pain in arm. In June 2018, the outcome of the pain in arm was recovered/resolved. On an unknown date, the outcome of the injection site erythema and swelling arm were not recovered/not resolved and the outcome of the injection site rash and injection site warmth were recovering/resolving. The reporter considered the pain in arm, injection site erythema, injection site rash, injection site warmth and swelling arm to be related to SHINGRIX. Additional details were provided as follows: The patient had a history of breakouts from mosquitoes. The patient received the SHINGRIX (left arm) in the late afternoon around 4:00 pm on and her arm was sore for three days and then resolved on the 4th day after the injection. In the evening before the reporting date, around 8:00 pm (9 days and 4 hours after vaccination) her arm started to bother her and the area got a bright red and hot rash around the injection site. In the morning of reporting date, the rash subsided a lot but it was still red and the top part of her arm was swollen. The contact details of the healthcare professional was provided.
rash; Warm to touch; fever; This case was reported by a other health professional via call center representative and described the occurrence of injection site rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 4th October 2019, the patient received Shingrix. On 5th October 2019, 1 days after receiving Shingrix, the patient experienced injection site rash and skin warm. In October 2019, the patient experienced fever. On an unknown date, the outcome of the injection site rash, skin warm and fever were unknown.   It was unknown if the reporter considered the injection site rash, skin warm and fever to be related to Shingrix.  Additional details were provided as follows: This case was reported by the pharmacy intern. The age at vaccination was not reported. Right after receiving the Shingrix, the patient experienced rash on the vaccinated arm, the day after. Warm to touch appeared quickly a day after vaccination. Less than 2 weeks after vaccination, the patient experienced fever of 105 Fahrenheit. The rash was worst on the first day, and had gotten smaller by the time the patient went to the pharmacy on the 2nd or 3rd day. The reporter was unable to provide full details. The reporter did not consent to follow up. Time to onset for rash had been considered precisely in this case instead of immediately as it seems a general statement and there was a discrepancy in 2 source documents. This case is for 1 of the 3 patients, reported by the same reporter.
Had no reaction for 20 hrs. After that pain at site, chills, fever 100.1, & severe sinus headaches. Took Ibuprofen & fever went away. Have come down with severe sinus headaches since getting shot. Upper respiratory irritation continues too. No green mucus or bleeding. Some nights I have awoken with my CPAP machine reading 30 APH other nights 0 to 3 APH. Very unusual considering that I'm also on supplemental O2 with the CPAP.  If I was not on the CPAP & O2 during possible vaccine reaction, it could be bad. Still having bad sinus headaches. Cutting down on Propranolol to 20mg per day per my doctors orders.
my arm is red, swollen, and sore; my arm is red, swollen, and sore; my arm is red, swollen, and sore; bed ridden; symptoms like I had COVID all over again; chills; fever up to 104.5; This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (bed ridden), COVID-19 (symptoms like I had COVID all over again), CHILLS (chills), PYREXIA (fever up to 104.5) and INJECTION SITE ERYTHEMA (my arm is red, swollen, and sore) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no historical condition was reported).    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced BEDRIDDEN (bed ridden), COVID-19 (symptoms like I had COVID all over again), CHILLS (chills) and PYREXIA (fever up to 104.5). On 23-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (my arm is red, swollen, and sore), INJECTION SITE SWELLING (my arm is red, swollen, and sore) and INJECTION SITE PAIN (my arm is red, swollen, and sore). On 23-Feb-2021, BEDRIDDEN (bed ridden) and PYREXIA (fever up to 104.5) had resolved. At the time of the report, COVID-19 (symptoms like I had COVID all over again), CHILLS (chills), INJECTION SITE ERYTHEMA (my arm is red, swollen, and sore), INJECTION SITE SWELLING (my arm is red, swollen, and sore) and INJECTION SITE PAIN (my arm is red, swollen, and sore) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Feb-2021, Body temperature: upto 104.5.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient experienced pain with the vaccine injection. Since that time she has experienced pain and tingling in the arm, neck, shoulder, and fingers and is losing mobility with  her left arm.
Pt noted small area of redness adjacent to vaccination site. Gradually spread over the following day and sought medical care on 8/10. At time of evaluation found to have a confluent path of erythema and induration along posterior aspect of L upper arm. (+) warm, not tender. Reportedly was mildly itchy. No blisters or vesicles noted. Temp was 99.8 in office but no fever or chills reported. Pt felt otherwise well. Treating as allergic reaction but if any progression will treat for infection.
Information has been received regarding a case in litigation, from a lawyer, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unspecified date in October 2016, the patient was vaccinated with a dose of ZOSTAVAX as permanent prevention and protection against shingles and zoster-related injuries (prophylaxis) (strength, dose, route of administration, anatomical location, lot # and expiration date were not reported) due to a health care professional recommendation. On an unknown date, the patient experienced shingles (herpes zoster) and other zoster-related injuries despite being inoculated with the ZOSTAVAX vaccine (vaccination failure). On an unspecified date in November 2016, the patient was treated by a physician for shingles. It was also reported that the patient suffered serious physical, emotional and economic damages as a result. In addition, the patient would continue to suffer ongoing injuries, included but not limited to: mental and physical pain and suffering (Emotional distress and pain), extensive medical care and treatment for these injuries, significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of pre-existing conditions and activations of laten conditions, lost wages, loss of earning capacity and other losses and damages. At the time of report, the patient was not recovered from emotional distress and pain, and the outcome of the patient regarding the vaccination failure, herpes zoster, quality of life decreased and the pre-existing unspecified conditions aggravated was unknown. The reporter considered all aforementioned adverse eventsto be related to ZOSTAVAX. The reporter considered the events to be disabling, life-threatening and medically significant.